(Updated - December 17, 2015 8:42 AM EST)Goldman Sachs initiated coverage on Horizon Pharma (NASDAQ: HZNP) with a Buy rating ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE